Semaglutide vs Tirzepatide: What's the Difference?
Both are once-weekly injectable medications used for metabolic and weight management, but they act on different receptors. Here is what actually separates them.
By Hypergevity Editorial Team · Published September 3, 2026 · Updated September 3, 2026 · 8 min read
- Semaglutide is a GLP-1 receptor agonist; tirzepatide activates both GIP and GLP-1 receptors.
- Both are given as a once-weekly subcutaneous injection and are titrated upward slowly.
- Gastrointestinal side effects — nausea, constipation, diarrhea — are the most common with either medication.
- Neither medication is appropriate for everyone; eligibility is a clinical decision based on your history.
- Medication works alongside nutrition, protein intake, resistance training and sleep — not instead of them.
Semaglutide and tirzepatide are two of the most widely discussed prescription medications in metabolic health. They are often mentioned interchangeably, but they are not the same molecule and they do not act on the same receptors. Understanding the difference helps you have a more useful conversation with a licensed provider.
What is semaglutide?
Semaglutide is a GLP-1 receptor agonist. GLP-1 (glucagon-like peptide-1) is a hormone your gut releases after eating. It supports insulin release when glucose is elevated, slows how quickly the stomach empties, and signals fullness in the brain. Semaglutide mimics that hormone with a much longer duration of action, which is why it is dosed once weekly.
What is tirzepatide?
Tirzepatide is a dual agonist: it activates the GLP-1 receptor and also the GIP (glucose-dependent insulinotropic polypeptide) receptor. GIP is a second gut hormone involved in insulin response and nutrient handling. Adding GIP activity is the core pharmacological difference between the two medications.
Side-by-side comparison
| Semaglutide | Tirzepatide | |
|---|---|---|
| Drug class | GLP-1 receptor agonist | Dual GIP and GLP-1 receptor agonist |
| Administration | Once-weekly subcutaneous injection | Once-weekly subcutaneous injection |
| Dosing approach | Started low and increased in steps over weeks | Started low and increased in steps over weeks |
| Most common side effects | Nausea, vomiting, diarrhea, constipation, abdominal discomfort | Nausea, vomiting, diarrhea, constipation, abdominal discomfort |
| Monitoring | Symptom response, tolerability, relevant labs as clinically indicated | Symptom response, tolerability, relevant labs as clinically indicated |
Both medications carry a boxed warning in their FDA-approved labeling regarding thyroid C-cell tumors observed in rodents, and both are contraindicated for people with a personal or family history of medullary thyroid carcinoma or MEN 2. Read the full labeling and disclose your complete history to your provider.
Which one is 'better'?
That question cannot be answered generically, and any site that answers it for you without knowing your history is guessing. The right choice depends on your medical history, other medications, prior tolerability, insurance and access considerations, and your provider's clinical judgment. Some people tolerate one better than the other; some are not candidates for either.
Factors a provider weighs
- Your medical and family history, including thyroid, pancreatic and gallbladder history
- Current medications, including insulin or sulfonylureas that affect hypoglycemia risk
- Prior experience with GLP-1 based medication, including side effects at specific doses
- Pregnancy, breastfeeding or plans to conceive
- Your ability to maintain adequate protein intake and physical activity while treated
What both medications have in common
Both are titrated slowly to reduce gastrointestinal side effects. Both work best when treatment is paired with a protein-forward eating pattern, resistance training to protect lean mass, hydration and adequate sleep. And with both, stopping the medication usually means appetite signals return, which is why long-term planning is part of the clinical conversation from the start.
If you are earlier in your research, our guide on how GLP-1 medications work explains the underlying biology in more detail, and our guide to preserving lean mass covers the training and protein side of treatment.
Frequently asked questions
- Are semaglutide and tirzepatide the same drug with different names?
- No. They are different molecules. Semaglutide acts on the GLP-1 receptor; tirzepatide acts on both the GIP and GLP-1 receptors.
- Do both require a prescription?
- Yes. In the United States both are prescription medications and require evaluation by a licensed provider.
- Can I switch from one to the other?
- Switching is a clinical decision. It involves restarting at an appropriate dose rather than matching numbers between medications, so it should only be done under provider guidance.
- How quickly do they work?
- Appetite and fullness changes are often noticed in the first weeks, but dose titration takes place over months. Response varies between individuals and is not guaranteed.
Talk to a licensed provider about medical weight management
Complete a confidential online intake. A licensed U.S. provider reviews your history and decides whether treatment is appropriate — payment never guarantees a prescription.
References
- Semaglutide Injection — Drug Information — MedlinePlus, U.S. National Library of Medicine
- Tirzepatide Injection — Drug Information — MedlinePlus, U.S. National Library of Medicine
- Prescription Medications to Treat Overweight & Obesity — National Institute of Diabetes and Digestive and Kidney Diseases (NIH)
- Medications Containing Semaglutide Marketed for Type 2 Diabetes or Weight Loss — U.S. Food and Drug Administration
Prescription products require an online consultation with a healthcare professional who will determine if a prescription is appropriate. You will be notified through email, text/SMS, or your online Hypergevity portal if approved. Compounded medications are not FDA-approved and have not been evaluated by the FDA for safety or effectiveness. If receiving treatment for other conditions, your provider may prescribe FDA-approved generic or brand prescription drugs. If you are unsure, always ask your provider which medication they are prescribing.